SpineGuard reports on its Annual Shareholders’ Meeting of June 29, 2023
29 Junio 2023 - 11:00AM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company
that deploys its DSG (Dynamic Surgical Guidance) sensing technology
to secure and streamline the placement of bone implants, reports on
its Annual Shareholders’ Meeting held on June 29, 2023 at 10:00am,
on its second call at the offices of the law firm Ashurst Paris,
located at 18 square Edouard VII, 75009 Paris.
The shareholders present or represented were holding 8,922,729
shares representing a quorum of 22.85%.
All the resolutions of this Annual General Meeting were adopted
with the exception of the 17th resolution as recommended by the
Board of Directors.
To close the Shareholders meeting, Pierre Jérôme, Chairman,
CEO and Co-founder of SpineGuard, “thanked all the shareholders
for their votes and said that no draw was processed since the setup
of the OCA HORIZON equity line announced on May 31st ”.
The minutes of the shareholders' meeting will be available
within the legal deadlines on SpineGuard’s website:
www.spineguard.com.
Upcoming financial events:
- H1 2023 revenue, July 11, 2023, after market
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 95,000 surgical
procedures worldwide. Twenty-four studies published in
peer-reviewed scientific journals have demonstrated the multiple
benefits DSG® offers to patients, surgeons, surgical staff and
hospitals. Building on these strong fundamentals and several
strategic partnerships, SpineGuard has expanded the scope of its
DSG® technology in innovative applications such as the « smart »
pedicle screw, the DSG Connect visualization and registration
interface, dental implantology and surgical robotics. DSG® was
co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D.,
and Alain Vanquaethem, Biomedical Engineer. SpineGuard has engaged
in multiple ESG initiatives.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230629703585/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com
SpineGuard Anne-Charlotte Millard CFO Tel: +33 1 45 18 45
19 ac.millard@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin Tel: +33 1 44 71 94 94 spineguard@newcap.eu
Spineguard (EU:ALSGD)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Spineguard (EU:ALSGD)
Gráfica de Acción Histórica
De May 2023 a May 2024